当前位置:首页 - 行情中心 - 博雅生物(300294) - 财务分析

博雅生物

(300294)

  

流通市值:137.21亿  总市值:137.21亿
流通股本:5.04亿   总股本:5.04亿

博雅生物(300294)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润3.97亿元,每股收益0.79元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益748776.28万元,未分配利润266541.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产840114.48万元,负债91338.20万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入1,734,904,402.711,245,107,779.6895,735,666.55448,452,537.26
营业总成本1,279,267,786.34853,438,255.57590,060,239.82301,267,242.96
营业利润477,254,740.43480,304,669.9366,571,693.97174,748,795.31
利润总额477,713,553.09480,425,274.87367,849,596.68176,273,975.17
净利润396,528,491.41412,432,277.86315,702,965.44151,760,842.43
其他综合收益2,363,203.42---
综合收益总额398,891,694.83412,432,277.86315,702,965.44151,760,842.43
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计5,058,350,132.046,588,378,918.746,646,803,608.816,612,770,411.54
非流动资产合计3,342,794,636.951,569,568,539.971,376,542,132.171,380,080,059.34
资产总计8,401,144,768.998,157,947,458.718,023,345,740.987,992,850,470.88
流动负债合计750,375,923.41548,572,730.16508,252,682.55469,707,474.59
非流动负债合计163,006,070.8627,391,572.7229,839,215.0250,556,654.49
负债合计913,381,994.27575,964,302.88538,091,897.57520,264,129.08
归属于母公司股东权益合计7,487,150,950.417,581,179,585.657,484,446,267.397,471,775,464.59
股东权益合计7,487,762,774.727,581,983,155.837,485,253,843.417,472,586,341.8
负债和股东权益合计8,401,144,768.998,157,947,458.718,023,345,740.987,992,850,470.88
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计1,683,847,519.891,243,921,430.2848,791,859.26433,665,060.89
经营活动现金流出小计1,384,066,263981,512,776.41637,131,225.65309,793,350.76
经营活动产生的现金流量净额299,781,256.89262,408,653.79211,660,633.61123,871,710.13
投资活动现金流入小计6,858,693,703.624,877,717,611.24,116,175,981.37922,013,238.76
投资活动现金流出小计7,506,227,480.394,931,280,768.22,881,673,432.951,151,177,771.48
投资活动产生的现金流量净额-647,533,776.77-53,563,1571,234,502,548.42-229,164,532.72
筹资活动现金流入小计5,237,675.715,237,675.715,237,675.71-
筹资活动现金流出小计308,711,818175,448,324.2153,212,365.0452,856.64
筹资活动产生的现金流量净额-303,474,142.29-170,210,648.49-147,974,689.33-52,856.64
汇率变动对现金及现金等价物的影响-6,966.56,966.54485.54
现金及现金等价物净增加额-651,226,662.1738,641,814.81,298,195,459.24-105,345,193.69
期末现金及现金等价物余额1,298,571,389.971,988,439,866.943,247,993,511.381,844,452,858.45
最新报告期:2025-03-31
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华安证券谭国超,陈珈蔚0.961.111.282025-03-31
中金公司全芳,张琎,朱言音1.071.19--2025-03-26
中信建投刘若飞,贺菊颖1.101.231.392025-03-24
华源证券刘闯,李强1.021.201.342025-03-24
国投证券马帅,胡雨晴1.051.201.382025-03-24
TOP↑